RESUMO
AIM: To examine the effect of aqueous fructus aurantii immaturus (FAI) extracts on the intestinal plexus of cathartic colons. METHODS: Cathartic colons were induced in rats with dahuang, a laxative used in traditional Chinese medicine. Once the model was established (after approximately 12 wk), rats were administered mosapride (1.54 mg/kg) or various doses of aqueous FAI extracts (1-4 g/kg) for 14 d. Transit function was assessed using an ink propulsion test. Rats were then sacrificed, and the ultramicrostructure of colonic tissue was examined using transmission electron microscopy. The expression of the 5-hydroxytryptamine receptor 4 (5-HTR4) and neurofilament-H was assessed in colon tissues using real-time PCR, Western blot, and immunohistochemistry. RESULTS: Mosapride and high dose (4 g/kg) of aqueous FAI extracts significantly improved the bowel movement in cathartic colons compared to untreated model colons as measured by the intestinal transit rate (70.06 ± 7.25 and 72.02 ± 8.74, respectively, vs 64.12 ± 5.19; P < 0.05 for both). Compared to controls, the ultramicrostructure of cathartic colons showed signs of neural degeneration. Treatment with mosapride and aqueous FAI extracts resulted in recovery of ultrastructural pathology. Treatment with mosapride alone upregulated the gene and protein expression of 5-HTR4 compared to untreated controls (P < 0.05 for both). Treatment with aqueous FAI extracts (≥ 2 g/kg) increased 5-HTR4 mRNA levels (P < 0.05), but no change in protein level was observed by Western blot or immunohistochemistry. The mRNA and protein levels of neurofilament-H were significantly increased with mosapride and ≥ 2 g/kg aqueous FAI extracts compared to controls (P < 0.05 for all). CONCLUSION: Aqueous FAI extracts and mosapride strengthen bowel movement in cathartic colons via increasing the expression of 5-HTR4 and neurofilament-H.
Assuntos
Catárticos/farmacologia , Colo/efeitos dos fármacos , Colo/inervação , Constipação Intestinal/tratamento farmacológico , Medicamentos de Ervas Chinesas/farmacologia , Motilidade Gastrointestinal/efeitos dos fármacos , Plexo Mientérico/efeitos dos fármacos , Animais , Benzamidas/farmacologia , Colo/metabolismo , Colo/ultraestrutura , Constipação Intestinal/patologia , Constipação Intestinal/fisiopatologia , Defecação/efeitos dos fármacos , Modelos Animais de Doenças , Masculino , Morfolinas/farmacologia , Plexo Mientérico/metabolismo , Plexo Mientérico/fisiopatologia , Plexo Mientérico/ultraestrutura , Degeneração Neural , Proteínas de Neurofilamentos/genética , Proteínas de Neurofilamentos/metabolismo , Fitoterapia , Plantas Medicinais , RNA Mensageiro/metabolismo , Ratos Sprague-Dawley , Receptores 5-HT4 de Serotonina/genética , Receptores 5-HT4 de Serotonina/metabolismo , Fatores de Tempo , Regulação para CimaRESUMO
OBJECTIVE: To observe the effect of Draconis Sanguis-containing serum on the expressions of NGF, BDNF, CNTF, LNG-FR, TrkA, GDNF, GAP-43 and NF-H in Schwann cells, and investigate the possible mechanism of Draconis Sanguis to promote peripheral nerve regeneration. METHOD: SD rats were randomly divided into 2 groups: the Draconis Sanguis group (orally administered with Draconis Sanguis-containing balm solution) and the blank group (equivoluminal balm) to prepare Draconis Sanguis-containing serum and blank control serum. Schwann cells were extracted from double sciatic nerves of three-day-old SD rats, divided into 2 groups: the Draconis Sanguis group and the blank control group, and respectively cultured with 10% Draconis Sanguis-containing serum or blank control serum. The mRNA expressions of NGF, BDNF, CNTF and other genes in Schwann cells were measured by RT-PCR analysis 48 hours later. RESULT: Most of the Schwann cells were bipolar spindle and arranged shoulder to shoulder or end to end under the microscope and identified to be positive with the immunocytochemical method. To compare with the blank group, mRNA expressions of NGF, LNGFR, GDNF and GAP-43 significantly increased (P < 0.01). Whereas that of BDNF decreased significantly (P < 0.05), and so did that of TrkA, CNTF (P < 0.01), with no remarkable difference in NF-H-mRNA. CONCLUSION: Traditional Chinese medicine Draconis Sanguis may show effect in nerve regeneration by up-regulating mRNA expressions of NGF, LNGFR, GDNF and GAP-43 and down-regulating mRNA expressions of TrkA, BDNF and CNTF.
Assuntos
Arecaceae/química , Medicamentos de Ervas Chinesas/farmacologia , Expressão Gênica/efeitos dos fármacos , Células de Schwann/efeitos dos fármacos , Soro/química , Animais , Fator Neurotrófico Derivado do Encéfalo/genética , Fator Neurotrófico Derivado do Encéfalo/metabolismo , Células Cultivadas , Fator Neurotrófico Ciliar/genética , Fator Neurotrófico Ciliar/metabolismo , Proteína GAP-43/genética , Proteína GAP-43/metabolismo , Fator Neurotrófico Derivado de Linhagem de Célula Glial/genética , Fator Neurotrófico Derivado de Linhagem de Célula Glial/metabolismo , Masculino , Fator de Crescimento Neural/genética , Fator de Crescimento Neural/metabolismo , Regeneração Nervosa/efeitos dos fármacos , Proteínas de Neurofilamentos/genética , Proteínas de Neurofilamentos/metabolismo , Ratos , Ratos Sprague-Dawley , Receptor trkA/genética , Receptor trkA/metabolismo , Células de Schwann/fisiologiaRESUMO
The ability of mesenchymal stem cells (MSCs) to differentiate into neuronal lineage determines the potential of these cells as a substrate for a cell replacement therapy. In this paper we compare the neurogenic potential of MSCs isolated from bone marrow (BMSC), subcutaneous adipose tissue (AD MSC) and menstrual blood (eMSC). It was found that the native eMCSs, BMSCs and AD MSCs express neuronal marker ß-III-tubulin with a frequency of 90, 50 and 14%, respectively. We also showned that eMSCs have a high endogenous level of brain-derived neurotrophic factor (BDNF), whereas the BMSCs and the AD MSCs are characterized by low basal BDNF levels. As induction of neuronal differentiation in the studied MSCs using differentiation medium containing B27 and N2 supplements, 5-azacytidine, retinoic acid, IBMX and dbcAMF caused changes in the cells morphology, the increased expression of ß-III-tubulin, and the appearance of neuronal markers GFAP, NF-H, NeuN and MAP2. BDNF secretion during differentiation was significantly enhanced in the BMSCs and decreased in the eMSCs cultures. However, no correlation between the basal and induced levels of the neuronal markers expression and BDNF secretion in the studied MSCs has been established.
Assuntos
Fator Neurotrófico Derivado do Encéfalo/metabolismo , Endométrio/metabolismo , Células-Tronco Mesenquimais/metabolismo , Neurônios/metabolismo , 1-Metil-3-Isobutilxantina/farmacologia , Antígenos Nucleares/genética , Antígenos Nucleares/metabolismo , Azacitidina/farmacologia , Biomarcadores/metabolismo , Células da Medula Óssea/citologia , Células da Medula Óssea/efeitos dos fármacos , Células da Medula Óssea/metabolismo , Bucladesina/farmacologia , Diferenciação Celular/efeitos dos fármacos , Endométrio/citologia , Endométrio/efeitos dos fármacos , Feminino , Expressão Gênica , Proteína Glial Fibrilar Ácida/genética , Proteína Glial Fibrilar Ácida/metabolismo , Humanos , Menstruação , Células-Tronco Mesenquimais/citologia , Células-Tronco Mesenquimais/efeitos dos fármacos , Proteínas Associadas aos Microtúbulos/genética , Proteínas Associadas aos Microtúbulos/metabolismo , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/metabolismo , Proteínas de Neurofilamentos/genética , Proteínas de Neurofilamentos/metabolismo , Neurônios/citologia , Neurônios/efeitos dos fármacos , Gordura Subcutânea/citologia , Gordura Subcutânea/efeitos dos fármacos , Gordura Subcutânea/metabolismo , Tretinoína/farmacologia , Tubulina (Proteína)/genética , Tubulina (Proteína)/metabolismoRESUMO
AIMS: Deduce whether the isoflavone genistein blunts the effect of ischaemia to the retina. METHODS: Ischaemia was induced in rats by raising the intraocular pressure (120 mm Hg) for 50 min. Genistein (10 mg/kg) was injected intraperitoneally 1 h before and after ischaemia. Seven days after ischaemia, the level of mRNAs for neurofilament light (NF-L), caspase 3, caspase 8, glial fibrillary acidic protein (GFAP), poly-ADP ribose polymerase (PARP), Thy-1 and proteins (GFAP, NF-L, PARP) in whole retinas were determined. NF-L and tubulin proteins in optic nerves were also determined. Retinas were also processed for the localization of choline acetyltransferase (ChAT) and GFAP immunoreactivities. RESULTS: Ischaemia caused a significant reduction in ganglion cell proteins in the optic nerve (NF-L and tubulin) and retina (NF-L). Retinal Thy-1 (mRNA and protein) and NF-L (mRNA) were also reduced while mRNAs of caspase 3, caspase 8, PARP and GFAP (also protein) were increased. Changes in the mRNAs and proteins induced by ischaemia were significantly blunted by genistein with the exception of the increase in GFAP and PARP protein/mRNA levels. Ischaemia-induced changes in the localization of ChAT were also clearly attenuated by genistein treatment. CONCLUSIONS: Genistein blunts most of the damaging effects caused to the retina by ischaemia.
Assuntos
Genisteína/uso terapêutico , Pressão Intraocular , Fitoestrógenos/uso terapêutico , Traumatismo por Reperfusão/prevenção & controle , Doenças Retinianas/prevenção & controle , Animais , Caspase 3/genética , Caspase 8/genética , Ciclofilinas/genética , Modelos Animais de Doenças , Feminino , Técnica Indireta de Fluorescência para Anticorpo , Proteína Glial Fibrilar Ácida/metabolismo , Injeções Intraperitoneais , Proteínas de Neurofilamentos/genética , Hipertensão Ocular/complicações , Hipertensão Ocular/genética , Poli Adenosina Difosfato Ribose/genética , Proteínas/genética , RNA Mensageiro/genética , Ratos , Ratos Wistar , Traumatismo por Reperfusão/etiologia , Traumatismo por Reperfusão/genética , Doenças Retinianas/etiologia , Doenças Retinianas/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Antígenos Thy-1/genéticaRESUMO
BACKGROUND: The multipotency of stromal cells has been studied extensively. It has been reported that mesenchymal stromal cells (MSC) are capable of differentiating into cells of multilineage. Different methods and reagents have been used to induce the differentiation of MSC. We investigated the efficacy of different growth factors in inducing MSC differentiation into neurons. METHODS: MSC from human BM were isolated and cultured in media supplemented with 10% FBS. These cells were identified and later induced to differentiate into neuron-like cells using different neurotrophic factors. Three different growth factors were used, either alone or in combination: brain-derived neurotrophic factor, epidermal growth factor and neural growth factor. RESULTS: After 10 days of culture, MSC showed neuron-like morphologic changes. Immunostaining showed that these cells expressed markers for neurons (growth-associated protein-43, neuron-specific nuclear protein and neurofilament 200 kDa) and expression of these markers suggested the transition of immature stages to more mature stages of neuron-like cells. DISCUSSION: Our results show that BM-derived MSC can differentiate not only into target cells of mesodermal origin but also neuron-like cells of ectodermal origin. The findings show that a combination of growth factors is more effective in inducing MSC into neuron-like cells.
Assuntos
Células da Medula Óssea/citologia , Células-Tronco Mesenquimais/citologia , Neurônios/citologia , Adipócitos/citologia , Adipócitos/metabolismo , Fosfatase Alcalina/análise , Fosfatase Alcalina/genética , Antígenos Nucleares/análise , Antígenos Nucleares/genética , Células da Medula Óssea/efeitos dos fármacos , Células da Medula Óssea/metabolismo , Fator Neurotrófico Derivado do Encéfalo/farmacologia , Técnicas de Cultura de Células/métodos , Diferenciação Celular/efeitos dos fármacos , Células Cultivadas , Condrócitos/citologia , Condrócitos/metabolismo , Fator de Crescimento Epidérmico/farmacologia , Citometria de Fluxo , Proteína GAP-43/análise , Proteína GAP-43/genética , Humanos , Imuno-Histoquímica , Imunofenotipagem , Células-Tronco Mesenquimais/efeitos dos fármacos , Células-Tronco Mesenquimais/metabolismo , Fatores de Crescimento Neural/farmacologia , Proteínas do Tecido Nervoso/análise , Proteínas do Tecido Nervoso/genética , Proteínas de Neurofilamentos/análise , Proteínas de Neurofilamentos/genética , Neurônios/metabolismo , Osteoblastos/citologia , Osteoblastos/metabolismo , Osteocalcina/análise , Osteocalcina/genética , Osteopontina/análise , Osteopontina/genética , Reação em Cadeia da Polimerase Via Transcriptase ReversaRESUMO
Folate deficiency contributes to a variety of age-related neurological and psychological disorders including amyotrophic lateral sclerosis (ALS). The environmental neurotoxin arsenic has recently been linked with decreased neurofilament (NF) content in peripheral nerve. We examined herein, whether or not folate deprivation potentiated the impact of arsenic on NF dynamics. Arsenic inhibited translocation of NFs into axonal neurites in culture and increased perikaryal NF phosphoepitopes. Folate deprivation potentiated the impact of arsenic on these phenomena. Supplementation with S-adenosyl methionine (SAM) attenuated the impact of folate deprivation on arsenic neurotoxicity, consistent with the decrease in SAM following folate deprivation and the requirement for SAM-mediated methylation for arsenic bioelimination. These findings demonstrate how key nutritional deficiencies can potentiate the impact of enrivonmental neurotoxins.
Assuntos
Arsênio/toxicidade , Ácido Fólico/administração & dosagem , Doenças do Sistema Nervoso/induzido quimicamente , S-Adenosilmetionina/administração & dosagem , Esclerose Lateral Amiotrófica/induzido quimicamente , Axônios/ultraestrutura , Bucladesina/farmacologia , Linhagem Celular , Citoesqueleto/efeitos dos fármacos , Ácido Fólico/fisiologia , Proteínas de Fluorescência Verde/genética , Metilação , Doenças do Sistema Nervoso/prevenção & controle , Neuritos/fisiologia , Neuritos/ultraestrutura , Proteínas de Neurofilamentos/análise , Proteínas de Neurofilamentos/genética , Proteínas de Neurofilamentos/metabolismo , Fosforilação , Proteínas Recombinantes de Fusão , TransfecçãoRESUMO
The aim of this investigation was to determine whether an ingredient of green tea, epigallocatechin gallate (EGCG) could attenuate oxidative stress-induced degeneration of the retina as occurs in age-related macular degeneration (AMD) and glaucoma. Initial in vitro studies on brain membranes showed that EGCG was approximately 10 times more potent than trolox (vitamin E analogue) at attenuating lipid peroxidation caused by the nitric oxide donor, sodium nitroprusside (SNP). Subsequent immunohistochemical studies revealed that following an intraocular injection of SNP retinal photoreceptors are affected. This was supported by electroretinogram (ERG) recordings which showed both the a- and b-wave amplitudes to be significantly reduced. RT-PCR and Western blotting techniques showed that SNP caused a significant decrease in photoreceptor-specific markers (RET-P1, rhodopsin kinase), an increase in the cell death marker caspase-3, and no change in the ganglion cell specific markers, neurofilament (NF-L) and Thy-1. Importantly, when EGCG was co-injected, the detrimental effects to the retina caused by SNP were significantly blunted. The conclusion reached from this study is that EGCG is a powerful antioxidant and when injected into the eye with SNP attenuated the detrimental influence of SNP to retinal photoreceptors. Since oxidative stress has been implicated in retinal diseases like AMD and glaucoma this study provides "proof of principle" for the idea that daily intake of EGCG may help individuals suffering from retinal diseases where oxidative stress is implicated.
Assuntos
Catequina/análogos & derivados , Fármacos Neuroprotetores/uso terapêutico , Estresse Oxidativo , Degeneração Retiniana/tratamento farmacológico , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Caspase 3/genética , Caspase 3/metabolismo , Catequina/uso terapêutico , Colina O-Acetiltransferase/metabolismo , Eletrorretinografia/métodos , Regulação da Expressão Gênica/efeitos dos fármacos , Regulação da Expressão Gênica/fisiologia , Imuno-Histoquímica/métodos , Marcação In Situ das Extremidades Cortadas/métodos , Peroxidação de Lipídeos/efeitos dos fármacos , Proteínas de Neurofilamentos/genética , Proteínas de Neurofilamentos/metabolismo , Proteína Quinase C/metabolismo , RNA Mensageiro/metabolismo , Ratos , Degeneração Retiniana/etiologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos , Opsinas de Bastonetes/genética , Opsinas de Bastonetes/metabolismo , Rodopsinas Sensoriais/genética , Rodopsinas Sensoriais/metabolismo , Antígenos Thy-1/genética , Antígenos Thy-1/metabolismo , Ácido gama-Aminobutírico/metabolismoRESUMO
We present a simple method for neural cell fate specification directly from mouse embryonic stem cells (ES cells) in serum-free conditions in the absence of embryoid body formation. Dissociated ES cells were cultured in serum-free media supplemented with vitamin B12 and heparin, but without any expensive cytokines. After 14 days in culture, beta-tubulin type III (TuJ1) and tyrosine hydroxylase (TH)-positive colonies were detected by immunocytochemical examinations. In addition, specific gene analyses by RT-PCR demonstrated expression of an early central nerve system, mature neuron, and midbrain dopaminergic neuron-specific molecules (i.e., nestin, middle molecular mass neurofilament protein, Nurr1, and TH, respectively). Dopamine was also detected in the culture media by reverse-phase HPLC analysis. These facts indicate that addition of vitamin B12/heparin to serum-free culture media induced neurons from ES cells, which included cells that released dopamine. Other supplements, such as putrescine, biotin, and Fe2+, could not induce neurons from ES cells by themselves, but produced synergistic effects with vitamin B12/heparin. The rate of TuJ1+/TH+ colony formation was increased threefold and the amounts of dopamine released increased 1.5-fold by the addition of a mixture of putrescine, biotin, and Fe2+ to vitamin B12/heparin culture media. Our method is a simple tool to differentiate ES cells to dopaminergic neurons for the preparation of dopamine-releasing cells for the cell transplantation therapy of Parkinson's disease. In addition, this method can facilitate the discovery of soluble factors and genes that can aid in the induction of the ES cell to its neural fate.
Assuntos
Diferenciação Celular/efeitos dos fármacos , Indução Embrionária/efeitos dos fármacos , Heparina/farmacologia , Neurônios/citologia , Transplante de Células-Tronco/métodos , Células-Tronco/efeitos dos fármacos , Vitamina B 12/farmacologia , Animais , Biotina/farmacologia , Diferenciação Celular/fisiologia , Linhagem Celular , Sistema Nervoso Central/embriologia , Sistema Nervoso Central/crescimento & desenvolvimento , Meios de Cultura Livres de Soro/química , Dopamina/análise , Sinergismo Farmacológico , Regulação da Expressão Gênica no Desenvolvimento , Imuno-Histoquímica , Proteínas de Filamentos Intermediários/genética , Ferro/farmacologia , Camundongos , Proteínas do Tecido Nervoso/genética , Nestina , Proteínas de Neurofilamentos/genética , Neurônios/efeitos dos fármacos , Neurônios/fisiologia , Putrescina/farmacologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Células-Tronco/química , Células-Tronco/fisiologia , Tubulina (Proteína)/genética , Tirosina 3-Mono-Oxigenase/genéticaRESUMO
OBJECTIVE: To study the genes change of hMSC before and after differentiation into neuron-like cells. METHODS: hMSC were separated from marrow, cultured and expanded in culture medium. After hMSC being induced to differentiate with Shenqiye, Neuron-specific enolase (MSE), neurofilament (NF), and glial fibrillary acidic protein (GFAP) were detected by immunocytochemistry respectively. Using semi-quantitiative RT-PCR to detect ten genes change in hMSC before and after differentiation. Two genes were used to detect the gene sequence. RESULTS: When treated with the inducer--Shenqiye, hMSC exhibited neuronal phenotype. The expressions of NSE and NF in the neuron-like cells were positive, but the glial astrocyte marker GFAP was not found. hMSC expressed germline, ectodermal, endodermal and mesodermal genes prior to neurogenasis. After differentiation, germline genes did not express, while the expressions of endodermal and mesodermal genes were weakened. Ectodermal and neuronal genes expressed stronger. CONCLUSION: hMSC express multipotentiality, and the neural differentiation comprises quantitative modulation of gene expression rather than simple on-off switching of neural specific genes.
Assuntos
Diferenciação Celular/efeitos dos fármacos , Medicamentos de Ervas Chinesas/farmacologia , Células-Tronco Mesenquimais/citologia , Neurônios/citologia , Células Cultivadas , Combinação de Medicamentos , Expressão Gênica , Proteína Glial Fibrilar Ácida/genética , Proteína Glial Fibrilar Ácida/metabolismo , Humanos , Imuno-Histoquímica , Células-Tronco Mesenquimais/efeitos dos fármacos , Proteínas do Tecido Nervoso/biossíntese , Proteínas do Tecido Nervoso/genética , Proteínas de Neurofilamentos/biossíntese , Proteínas de Neurofilamentos/genética , Neurônios/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase ReversaRESUMO
Royal jelly (RJ) is known to have a variety of biological activities toward various types of cells and tissues of animal models, but nothing is known about its effect on brain functions. Hence, we examined the effect of oral administration of RJ on the mRNA expression of various neurotrophic factors, their receptors, and neural cell markers in the mouse brain. Our results revealed that RJ selectively facilitates the mRNA expression of glial cell line-derived neurotrophic factor (GDNF), a potent neurotrophic factor acting in the brain, and neurofilament H, a specific marker predominantly found in neuronal axons, in the adult mouse hippocampus. These observations suggest that RJ shows neurotrophic effects on the mature brain via stimulation of GDNF production, and that enhanced expression of neurofilament H mRNA is involved in events subsequently caused by GDNF. RJ may play neurotrophic and/or neuroprotective roles in the adult brain through GDNF.
Assuntos
Ácidos Graxos/administração & dosagem , Ácidos Graxos/farmacologia , Regulação da Expressão Gênica/efeitos dos fármacos , Hipocampo/efeitos dos fármacos , Hipocampo/metabolismo , Fatores de Crescimento Neural/genética , Proteínas de Neurofilamentos/genética , Administração Oral , Envelhecimento/fisiologia , Animais , DNA Complementar/genética , Fator Neurotrófico Derivado de Linhagem de Célula Glial , Masculino , Camundongos , RNA Mensageiro/genética , RNA Mensageiro/metabolismoRESUMO
Neurofilaments are the major components of the neuronal cytoskeleton, and accumulations of these proteins are associated with several important human diseases. Here we report the cloning and sequencing of bovine NF-M, the first NF-M cloned from a large domestic mammal. The bovine sequence proves to be generally more similar to that of human NF-M than the previously described mammalian sequences, suggesting that bovine neurofilaments are a useful model for biochemical studies of application to humans. However, we noted some unusual features within the 16 lys-ser-pro (KSP2) type phosphopeptide repeats and also note that the number of these repeats correlates well with the size of animal. We also characterized two in vitro calpain cleavage sites by direct peptide sequencing, finding that both are located in the glutamic acid rich E segment. Finally, we show biochemically that the more abundant and stable of these calpain fragments can also be detected in vivo.
Assuntos
Calpaína/metabolismo , DNA Complementar/genética , Proteínas de Neurofilamentos/genética , Proteínas de Neurofilamentos/metabolismo , Sequência de Aminoácidos , Animais , Anticorpos/metabolismo , Bovinos , Linhagem Celular Tumoral , Galinhas , Clonagem Molecular , Eletroforese em Gel de Poliacrilamida/métodos , Mapeamento de Epitopos , Humanos , Fragmentos de Peptídeos/genética , Fragmentos de Peptídeos/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Análise de Sequência de ProteínaRESUMO
1. In this study we investigated whether electrical stimulation accelerates the upregulation of Talpha1-tubulin and GAP-43 (regeneration-associated genes; RAGs) and the downregulation of the medium-molecular-weight neurofilament (NFM), in concert with stimulation-induced acceleration of BDNF and trkB gene expression and axonal regeneration. 2. Two weeks prior to unilateral femoral nerve transection and suture, fluorogold (Fluorochrome Inc., Denver) or fluororuby (Dextran tetramethylrhodamine, Mol. Probes, D-1817, Eugene, OR) was injected into quadriceps muscles of the left and right hindlimbs to label the femoral motoneuron pools as previously described. Over a period of 7 days, fresh spinal cords were processed for semiquantitation of mRNA by using in situ hybridization. 3. There was an increase in Talpha1-tubulin and GAP-43 mRNA and a decline in the NFM mRNA at 7 days after nerve suture and sham stimulation but not in intact nerves. In contrast, 1-h stimulation of sutured but not intact nerves dramatically accelerated the changes in gene expression: mRNA levels of Talpha1-tubulin and GAP-43 were significantly elevated above control levels by 2 days while NFM mRNA was significantly reduced by 2 days in the sutured nerves. Thereby, the neurofilament/tubulin expression ratio was reduced at 2 days after suture and stimulation, possibly allowing more tubulin to be transported faster into the growing axons to accelerate the elongation rate following stimulation. Importantly, the changes in RAGs and NFM gene expression were delayed relative to the accelerated upregulation of BDNF and trkB mRNA by electrical stimulation. 4. The temporal sequence of upregulation of BDNF and trkB, altered gene expression of RAGs and NFM, and accelerated axonal outgrowth from the proximal nerve stump are consistent with a key role of BDNF and trkB in mediating the altered expression of RAGs and, in turn, the promotion of axonal outgrowth after electrical stimulation.
Assuntos
Terapia por Estimulação Elétrica , Nervo Femoral/crescimento & desenvolvimento , Nervo Femoral/lesões , Neurônios Motores/metabolismo , Regeneração Nervosa/genética , Proteínas do Tecido Nervoso/genética , Animais , Axotomia , Fator Neurotrófico Derivado do Encéfalo/genética , Modelos Animais de Doenças , Regulação para Baixo/genética , Feminino , Nervo Femoral/metabolismo , Proteína GAP-43/genética , Regulação da Expressão Gênica/fisiologia , Cones de Crescimento/metabolismo , Neurônios Motores/citologia , Proteínas de Neurofilamentos/genética , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-Dawley , Receptor trkB/genética , Tubulina (Proteína)/genética , Regulação para Cima/genéticaRESUMO
Androgens are known to alter the morphology, survival, and axonal regeneration of lower motor neurons in vivo. To understand better the molecular mechanisms of androgen action in neurons, we created a model system by stably expressing the human androgen receptor (AR) in motor neuron hybrid cells. Motor neuron hybrid cells express markers consistent with anterior horn cells and can be differentiated into a neuronal phenotype. When differentiated in the presence of androgen, AR-expressing cells, but not control cells, exhibit a dose-dependent change in morphology: androgen-treated cells develop larger cell bodies and broader neuritic processes while continuing to express neuronal markers. In addition, androgen promotes the survival of AR-expressing cells, but not control cells, under low-serum conditions. Our results demonstrate a direct trophic effect of androgens on lower motor neurons, mediated through the AR expressed in this population of neurons.
Assuntos
Técnicas de Cultura de Células/métodos , Células Híbridas/citologia , Neurônios Motores/citologia , Neurônios Motores/efeitos dos fármacos , Testosterona/farmacologia , Biomarcadores , Sobrevivência Celular/efeitos dos fármacos , Colina O-Acetiltransferase/genética , Meios de Cultura , DNA Complementar , Regulação Enzimológica da Expressão Gênica , Humanos , Células Híbridas/química , Células Híbridas/enzimologia , Proteínas Associadas aos Microtúbulos/genética , Degeneração Neural , Proteínas de Neurofilamentos/genética , Fenótipo , Receptores Androgênicos/fisiologia , TransfecçãoRESUMO
The side-arm domain of neurofilament heavy-chain (NF-H) is heavily phosphorylated in axons. Much of this phosphate is located within a multiphosphorylation repeat (MPR) domain situated toward the carboxy terminus of the molecule. The MPR domain contains the repeat motif KSP of which there are two broad categories, KSPXX and KSPXK. In mouse NF-H, the KSPXK repeats are situated toward the latter part of the MPR domain. We have expressed in mammalian cells fragments of mouse NF-H side-arm containing all of the MPR domain, the latter part of the MPR domain containing the KSPXK repeats, and the complementary amino-terminal part of the MPR domain, which contains the KSPXX repeats. By cotransfecting these fragments with the neurofilament kinases cyclin-dependent kinase-5 (cdk-5)/p35 and glycogen synthase kinase-3alpha (GSK-3alpha), we show that cdk-5 induces cellular phosphorylation of the KSPXK-containing fragment of NF-H. Using the transfected fragments, we also map the epitopes for several commonly utilised NF-H monoclonal antibodies and describe the effects that phosphorylation by cdk-5 and GSK-3alpha have on their reactivities.
Assuntos
Proteínas Quinases Dependentes de Cálcio-Calmodulina/metabolismo , Quinases Ciclina-Dependentes , Proteínas de Neurofilamentos/metabolismo , Fragmentos de Peptídeos/metabolismo , Proteínas Serina-Treonina Quinases/metabolismo , Sequência de Aminoácidos , Animais , Western Blotting , Células COS , Proteínas Quinases Dependentes de Cálcio-Calmodulina/genética , Quinase 5 Dependente de Ciclina , Quinase 3 da Glicogênio Sintase , Quinases da Glicogênio Sintase , Camundongos , Proteínas de Neurofilamentos/genética , Fosforilação , Proteínas Serina-Treonina Quinases/genética , Sequências Repetitivas de Ácido Nucleico , TransfecçãoRESUMO
Injection of colchicine, a mitogen inhibitor, in the dorsal third ventricle induced the expression of the growth associated protein-43 (GAP-43) mRNA in some groups of cells of the adult rat brain. These mRNAs were detected by in situ hybridization histochemistry using an alkaline phosphatase labeled oligonucleotide probe. A substantial up-regulation of GAP-43 mRNA was noticed by the increase of both the number of positive cells and the intensity of the hybridization signal. These changes were observed in the hypothalamic nuclei located near the ventral third ventricle, namely the preoptic area, the supraoptic nucleus, the peri- and the paraventricular nuclei of the hypothalamus, the dorsal subnucleus of the ventromedial nucleus, the arcuate nucleus and the posterior part of the peri-mammillary region. Such abundant GAP-43 mRNA positive cells have not been observed in control adult rat hypothalamus. Since the positive cell number and shape initially suggested that these were neurons or astrocytes, double labeling in situ hybridization using both radioactive (for the detection of GFAP mRNA as a marker of astrocyte) and non-radioactive (for the detection of GAP-43 mRNA) probes was carried out. This demonstrated that these GAP-43 mRNA positive cells were not astrocytes. In addition enhanced GAP-43 mRNA expression was also found in some neuronal component, particularly in neurosecretory magnocells of the pareaventricular and the supraoptic nuclei. This up-regulation was further confirmed by the Northern blot analysis. About five fold increase in GAP-43 mRNA in the colchicine-treated hypothalamic tissue was shown.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Colchicina/farmacologia , Hipotálamo/metabolismo , Glicoproteínas de Membrana/biossíntese , Proteínas do Tecido Nervoso/biossíntese , Proteínas de Neurofilamentos/biossíntese , Animais , Northern Blotting , Proteína GAP-43 , Expressão Gênica/genética , Hibridização In Situ , Masculino , Glicoproteínas de Membrana/genética , Proteínas do Tecido Nervoso/genética , Proteínas de Neurofilamentos/genética , RNA Mensageiro/biossíntese , Ratos , Ratos WistarAssuntos
Axônios/metabolismo , Hipotálamo/metabolismo , Neurônios/metabolismo , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Animais , Sequência de Bases , Encefalinas/genética , Hipotálamo/citologia , Dados de Sequência Molecular , Peso Molecular , Proteínas de Neurofilamentos/genética , Precursores de Proteínas/genética , RNA Mensageiro/química , RatosRESUMO
Glucocorticoids, in conjunction with their cognate receptors, exert negative-feedback effects on the hypothalamus-pituitary-adrenal axis, suppressing adrenal steroid secretions. Two types of corticosteroid receptor, distinguishable by their ability to bind corticosterone, have been identified as classical mineralocorticoid (type I) and glucocorticoid (type II) receptors by cloning their complementary DNAs. The type I receptor controls the basal circadian rhythm of corticosteroid secretion. Both receptor types are involved in negative feedback, but the type II receptor may be more important for terminating the stress response as it is the only one to be increased in animals rendered more sensitive to corticosteroid negative-feedback effects. Here we create a transgenic mouse with impaired corticosteroid-receptor function by partially knocking out gene expression with type II glucocorticoid receptor antisense RNA. We use this animal to study the glucocorticoid feedback effect on the hypothalamus-pituitary-adrenal axis.